Tag Archives: Dr Madhukar Pai
Montreal (Canada): As a result of the overuse or misuse of antibiotics, antimicrobial resistant superbugs represent an extraordinary threat to global health. This threat is particularly great in India, the world’s largest consumer of antibiotics and the country facing the highest burden of tuberculosis (TB) in the world.
Antimicrobial resistance (AMR) is a global health threat, and it is estimated that by 2050, 10 million lives a year and a cumulative 100 trillion USD of economic output are at risk due to the rise of drug-resistant infections, if we do not find solutions to tackle the rise of drug resistant pathogens.
As the Prime Minister of India speaks to the US Congress this week, a neglected epidemic threatens India’s progress. It’s not Ebola or Zika — but rather tuberculosis, an ancient disease that silently kills one Indian every 90 seconds. In one year’s time, TB will sicken over 2.2 million Indians, and kill 300,000. Between 2006 and 2014, TB cost the Indian economy a staggering $340 billion. Because TB strikes people in the prime of their lives, it’s the 3rd leading cause of healthy years of life lost.
This article, one of the chapters of a new TB book called ‘Let’s Talk TB’ aimed at GPs in India (published by GP Clinics, available free at www.letstalktb.org) covers commonly asked questions by the primary care doctor about identification and referral of patients with suspected or confirmed DR-TB.
Even if the diagnostic hurdle is overcome, TB treatment in the private sector is far from standard. When private practitioners initiate anti-TB treatment (ATT), they tend to use drug regimens that are not recommended by WHO or the Standards of TB Care in India (STCI).
New Delhi: A new study from rural Chhattisgarh has found high prevalence of under-nutrition in tuberculosis (TB) patients, and a significant association between malnutrition and TB deaths.
New Delhi: To check the indiscriminate use of antibiotics, anti-tuberculosis and some other drugs in the country, the union health ministry has notified amendments to the Drugs and Cosmetics Act, 1940 under which a new provision Schedule H1 has been included to curb over the counter (OTC) sale of certain antibiotics and anti-tuberculosis drugs from March 1, 2014.
Tuberculosis (TB) continues to take a heavy toll on Indians. Every year, India reports over 2 million TB cases. TB kills nearly 280,000 men, women and children and is one of the leading causes of death in the country. In the past year, untreatable forms of drug-resistant TB cases have been reported in cities like Mumbai.
Toronto: Several diagnostics manufacturers and private Indian laboratories have signed an agreement that aims to halve the price patients pay for advanced tests for tuberculosis that is resistant to standard drugs.
Tuberculosis is one of India’s greatest public health challenges but the control programme lacks support from the media, the rich and the famous.